
France to deport Palestinian woman over antisemitic post featuring Hitler, halts Gaza evacuations
French Foreign Minister Jean-Noël Barrot told France Info radio that the woman "must leave the country" and that she "has no place" in France.
"No evacuation of any kind will take place until we have drawn the necessary conclusions from this investigation," Barrot said in the interview. He also vowed there would be a probe into how the Palestinian woman was able to get a student visa.
French Interior Minister Bruno Retailleau also expressed outrage over the incident, writing on X, "Hamas propagandists have no place in our country."
The now-expelled Sciences Po Lille student, who has not been identified by the French government, is accused of sharing a post with an image of Adolf Hitler that called for killing Jews.
According to a screenshot shared by the Jerusalem Post, the caption of the Hitler image—when translated by Grok from Arabic to English — read: "Kill the Jews everywhere. I don't want a Jewish lineage on this earth. You must kill them before they kill you."
In a thread on X, Sciences Po Lille said its administration became aware of the student's posts due to a report by Radio Monte-Carlo (RMC). The school condemned the posts, saying the content is in "direct contradiction with the values upheld by Sciences Po Lille." It added that the institution rejects antisemitism, discrimination, and incitement to hatred.
"France has no obligation to host international students who glorify terrorism, crimes against humanity, or antisemitism," French Minister of Higher Education Philippe Baptiste wrote. "Whether they come from Gaza or elsewhere, international students who express or relay such views have no place in our country, nor on our soil."
Baptiste also vowed that the French government would "do everything necessary to ensure that the case of the Palestinian student admitted to Sciences Po Lille, who shared extremely serious comments on social media, is handled with the utmost firmness."
French President Emmanuel Macron, who recently drew the ire of the U.S. and Israel over a plan to recognize a Palestinian state, has yet to comment on the matter regarding the student.
According to Macron's plan, Paris will recognize a Palestinian state in September. The country appeared to lay the groundwork for this at the United Nations earlier this week as it co-chaired a conference with Saudi Arabia. During the conference, several nations signed the "New York Declaration," which calls for Hamas to disarm and surrender control of Gaza to the Palestinian Authority. The declaration also demands that Israel evacuate its forces from the Strip.
The U.S. objected to the conference before it began, with State Department Spokesperson Tammy Bruce calling it "unproductive and ill-timed." She also dismissed it as a "publicity stunt that comes in the middle of delicate diplomatic efforts to end the conflict."
"As Secretary Rubio has made clear, this effort is a slap in the face to the victims of October 7th and a reward for terrorism. It keeps hostages trapped in tunnels," Bruce said. "The United States will not participate in this insult but will continue to lead real-world efforts to end the fighting and deliver a permanent peace. Our focus remains on serious diplomacy: not stage-managed conferences designed to manufacture the appearance of relevance."
Israeli U.N. Ambassador Danny Danon also objected to the conference.
"Israel has already agreed many times to a ceasefire. No token recognition and no UN resolution will change the basic fact that there are those in the world who fight terrorists and extremist forces and then there are those who turn a blind eye to them or resort to appeasement," Danon said in a statement.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Pharma CEOs downplay impact of tariffs amid rising cost concerns
Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU trade deal and associated tariffs will have limited impact. As per a new deal between the two global economic powerhouses, the EU will pay the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. Top-selling drugs such as AbbVie's Humira (adalimumab), MSD's Keytruda (pembrolizumab), and Novo Nordisk's Ozempic (semaglutide), for example, are manufactured in Europe and sent to the US, representing billion-dollar markets. Analysts from GlobalData's Pharma Strategic Intelligence team say that: 'Companies manufacturing pharmaceutical products in Europe will need to anticipate financial exposure when planning launches in the US due to the unfavourable gross to net dynamics, weakened pricing leverage with US payers, and slower commercial uptake as insurers reassess cost effectiveness due to the tariffs.' US President Donald Trump has had a sharp focus on the pharma industry since assuming office. Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country. Diederik Stadig, sector economist for TMT & healthcare at ING, wrote in a July note: 'A tariff would hurt consumers most of all, as they would feel the inflationary effect of tariffs directly when paying for prescriptions.' The European Federation of Pharmaceutical Industries and Associations (EFPIA), for example, has maintained that tariffs on medicines are ineffective. The group says such policies only hinder patient access to medicines. GlobalData also forecasts disruptions to launch planning, particularly late-stage assets with EU-based manufacturing and production planned for entry into the US. R&D budgets of pharmaceutical companies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds. The UK-EU trade deal announcement arrived in the middle of the pharma industry's Q2 reporting period, where execs were pressed on financial outlooks. In a Q2 earnings call, AbbVie's CEO Rob Michael said the US company is 'fairly insulated' from any tariff-related impacts in 2025, though caveated that the company would not speculate on the longer-term consequences. AstraZeneca shared the same sentiment. CEO Pascal Soriot said the British-Swedish drugmaker is 'almost self-sufficient in terms of supply,' adding that 'tariffs is not an issue that is really affecting us very much.' However, AstraZeneca is on a long list of pharma companies transferring manufacturing to the US. This includes a $4bn investment to build a new manufacturing plant in Virginia. Sanofi has outlaid $20bn to bolster US manufacturing through 2030 and Roche unveiled a similar $50bn investment strategy, to name just a couple. The team at GlobalData added: 'Ultimately, the recent US-EU trade deal has increased the level of uncertainty within the pharmaceutical industry, raising concerns on the potential of tariffs increasing past 15% in the future. 'While the full impact will take time to unfold, it will be interesting to see the adoption of different strategies on how the pharmaceutical industry looks to balance innovation, and ensuring patient access, while managing the pressures of tariffs as they unfold into a certain reality.' A critical part of the industry's future also relies on the outcome of the US government's Section 232 investigation into the drug sector. The probe, which Trump initiated to evaluate the role of medicine imports on national security, could result in further tariffs being imposed. MSD CEO Rob Davis said in the company's Q2 earnings call: 'We need to see more clarity both from the administration and just overall as to how exactly [the 15% tariff] is going to play out. It's still not clear exactly how this relates relative to the February investigation and the timing of whether these apply now or will be phased in until there's further guidance.' AbbVie's Michael said: 'We're having constructive discussions with the administration on sectoral tariffs. Clearly, the best way to motivate that is through tax incentives as well as a trade agenda that prioritises innovation. We're well positioned as a company, but we're not going to be able to really give you any details until we understand the outcome of the 232 investigation.' Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Pharma CEOs downplay impact of tariffs amid rising cost concerns" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.


CNN
7 minutes ago
- CNN
Ukraine is now Trump's war
Donald Trump Russia War in UkraineFacebookTweetLink Follow Vladimir Putin started it. Joe Biden didn't stop it. But, no matter his efforts to the contrary, this is the week in which Russia's invasion of Ukraine becomes US President Donald Trump's war. The most powerful office in the world doesn't always invite choices. Trump is mandated to address the biggest conflict in Europe since World War II because the United States was involved, under his predecessor, as Ukraine's key ally and sponsor. Trump could have dropped the war entirely. But instead, he chose to impose the force of his personality, initially through the idea he could end it in 24 hours, or a revised deadline of 100 days. Then he tried to navigate its personalities, cozying up to the Russian president initially, echoing his narratives and then berating Ukrainian President Volodymyr Zelensky publicly in the Oval Office. He hit his NATO allies hard, demanding they pay more for Europe's defense, which they did. And then the hard slog of diplomacy sputtered into gear, ultimately yielding very little. But it is in the last fortnight that Trump's decisions – and realizations – have turned this into a problem he now owns. He has seen Putin does not want peace. He has seen Ukraine urgently needs arms, and he tried to help, albeit in a lackluster way. He made the remarkable choice of responding to the usually dismissed nuclear saber-rattling of former Russian President Dmitry Medvedev, with harder nuclear threats about positioning US nuclear submarines closer to Russia. The US went from pausing military aid to Ukraine to threatening nuclear force against Russia in less than a month. As this week ends, with Trump's shortened deadline for a peace deal coming into view, he must make perhaps the most consequential decision of the conflict yet. Does he impose penalties – secondary tariffs against Russia's energy customers – that really hurt? Does he accept the US and its allies might need to endure a little pain economically, to inflict pain? Imposing serious secondary sanctions on India and China could roil the global energy market. Trump posted Monday he would be increasing tariffs on India because it was selling Russian crude on at a profit, and he didn't 'care how many people are being killed by the Russian War Machine,' although he did not provide details as to the new measures. India has not made it publicly clear if it intends to stop buying Russian energy products. China is utterly dependent on Russian oil and gas and simply cannot afford to stop buying it. CNN's Nick Paton Walsh describes the riveting escape plan hatched by Ukrainian forces to save the life of an injured soldier pinned down by Russian attacks. To avoid another a 'TACO' moment – short for Trump Always Chickens Out – Trump will have to cause some discomfort and will likely feel some back. Or he can look for an off-ramp, if one is offered to his special envoy Steve Witkoff in an expected Moscow visit this week. Trump could perhaps accept a bilateral meeting with Putin as a sign of progress toward peace. But even this backing down would still mean he has left his indelible imprint on the war – that, in the words of former US Secretary of State Colin Powell regarding Iraq, if the United States breaks it, they own it. Trump cannot have it both ways. It is in his nature to seek to be the fulcrum of all decisions, and the lightning rod of attention, on any given issue. Every turning point so far has been based around his personal choice and fancy. And with this comes a key lesson of the American presidency. Trump does not get to choose which problems are his, and which he can ignore. MAGA's America First platform may be about reducing Washington's global footprint, but it doesn't permit Trump to own solely his successes – and not his failures. Unless Trump reduces the footprint of American power globally to zero – incompatible with a presidential personality compelled to 'do' and agitate – there will always be some problems that are America's. He says he wants wars to stop. But that is not enough in itself. The wars have not all complied. Former US President Barack Obama inherited wars in both Iraq and Afghanistan. He ducked fast out of the former, and doubled down with a surge in the latter, which did not work. Afghanistan became Obama's war, even though it was a mess he had inherited. Trump in turn was passed that mess, and he handed his quick fix to Biden to execute, in the chaotic collapse of August 2021, widely paraded by Republicans as a Democrat failing. Trump faces the same problem of inheriting a crisis. He cannot wish or cajole the conflict to an end. The very battlefield deaths he mourns have sewn damage and grief afar, turning this into an existential war of survival for the Kremlin, and for the soul of Ukrainian society. Ukrainians want to live in peace, without nightly air raid sirens. Putin does not want peace, and instead his most recent maximalist demands amount to something tantamount to Ukrainian surrender. Ultimately, it is reflection of a harsh reality that this should be seen as Trump's war. It is the defining conflict of his presidency and of the post-9/11 era. Its outcome defines European security and Chinese belligerence over the next decade. China understands that and needs Russia to win. Europe understands that, and is arming itself so Russia does not see opportunity in the bloc's weakness. Whether Trump understands this and accepts discomforting, strident decisions with the consequences that follow, we will learn in the week ahead.


Fox News
37 minutes ago
- Fox News
European leaders decry Hamas video of Israeli captives: ‘unlimited inhumanity'
Leaders from across Europe responded in horror on Sunday to the recent footage released by Hamas of Israeli captives Rom Braslavski and Evyatar David, who were taken hostage nearly 670 days President Emmanuel Macron took to X to call the clearly emancipated state of both hostages a depiction of Hamas' "unlimited inhumanity" and decried it as "abject cruelty.""This is what Hamas embodies," he added. NETANYAHU RESPONDS AFTER ISRAELI HOSTAGE SEEN EMACIATED, DIGGING GRAVE: 'CRUELTY OF HAMAS HAS NO BOUNDARIES'Macron — who sent geopolitical shockwaves when he announced late last month that France would recognize the state of Palestine come September — renewed calls for an immediate ceasefire in the Gaza Strip, the return of all hostages and the full resumption of aid to the area. Macron on Sunday doubled down on his call for statehood and said ending the conflict is no longer enough."This effort must be accompanied by a political solution for the day after. That solution is the two-state solution, with Israel and Palestine living side by side in peace. It is the only possible path toward a future where justice, security, and dignity are guaranteed for all the peoples of the region," he said. Macron also made clear his position when it comes to Hamas, which some, including Israel and the U.S., have questioned following his push for Palestinian statehood."Let there be no ambiguity: within this political vision that we uphold, we demand the total demilitarization of Hamas, its complete exclusion from any form of governance, and recognition of Israel by the State of Palestine," he added. Macron's announcement prompted other Western nations to follow suit, including the U.K., Canada and even Germany — though Berlin's position on statehood has left room for some AMERICAN-ISRAELI HOSTAGE DETAILS STARVATION AND ABUSE BY HAMAS AS FAMILIES PUSH TRUMP FOR DEALGerman Chancellor Friedrich Merz echoed Macron's comments in an interview with German outlet Bild on Sunday and reportedly said the videos of the hostages "show that Hamas should no longer play a role in the future of Gaza."Merz also called on Israel not to block more aid to Gaza in retaliation for the cruelty. U.K. Foreign Secretary David Lammy also took to X on Sunday and called the videos "sickening" displays of Hamas "propaganda.""Every hostage must be released unconditionally," he said. "Hamas must disarm and have no control over Gaza. "We are working with partners on a long-term solution and plan for peace. This must begin with an immediate ceasefire, that frees the hostages, as well as removing inhumane aid restrictions," Lammy added. The recently released footage of two of the 50 hostages still held in Gaza coincided with a trip White House envoy Steve Witkoff took to Israel late last week, during which he visited with leaders and the families of the hostages in Tel has suggested the U.S. is now pushing for a comprehensive deal that would include a complete ceasefire and the return of all hostages, rather than incremental deals apparently favored by Israeli Prime Minister Benjamin reportedly told the families of the hostages that he believes the U.S. and the other allied nations are helping to mediate the negotiations, that a deal is close to being secured – though this belief has been expressed numerous times to no avail. Only American hostage Edan Alexander has been released under a deal not previously forged by the Biden and the then-incoming Trump administrations, which saw the release of 33 hostages by March.